Christopher & Banks Corporation
CBKCQ · OTC
10/31/2020 | 8/1/2020 | 5/2/2020 | 2/1/2020 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.01 | 0.01 | -0.00 | 0.00 |
| FCF Yield | -160.95% | 76.49% | -464.44% | 31.11% |
| EV / EBITDA | -17.60 | -10.59 | -10.19 | -45.17 |
| Quality | ||||
| ROIC | -9.31% | -13.08% | -11.96% | -3.67% |
| Gross Margin | 24.64% | 10.91% | 9.28% | 30.43% |
| Cash Conversion Ratio | 0.99 | -0.34 | 1.39 | -1.18 |
| Growth | ||||
| Revenue 3-Year CAGR | -10.07% | -8.29% | -5.58% | -1.58% |
| Free Cash Flow Growth | -327.11% | 119.78% | -535.66% | 570.61% |
| Safety | ||||
| Net Debt / EBITDA | -16.79 | -10.10 | -9.84 | -39.39 |
| Interest Coverage | -38.39 | -53.04 | -61.19 | -72.91 |
| Efficiency | ||||
| Inventory Turnover | 1.16 | 1.45 | 0.77 | 1.47 |
| Cash Conversion Cycle | 24.28 | 18.59 | 65.59 | 29.73 |